Notice of Effectiveness (effect)
26 Dezembro 2018 - 9:02AM
Edgar (US Regulatory)
|
UNITED STATES
|
|
SECURITIES AND EXCHANGE COMMISSION
|
|
Washington, D.C. 20549
|
NOTICE OF EFFECTIVENESS
|
|
|
|
Effective Date:
|
December 21,
2018
|
|
Accession Number:
|
0001193125-18-348313
|
|
Submission Type:
|
POS AM
|
|
CIK:
|
0001114220
|
|
Company Name:
|
KERYX BIOPHARMACEUTICALS INC
|
|
File Number:
|
333-214513
|
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025
Notícias em tempo-real sobre Keryx Biopharmaceuticals, Inc. (delisted) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Keryx Biopharmaceuticals Inc
